WALTHAM, Mass.--(BUSINESS WIRE)--Today Augmenix, Inc. (http://www.spaceoar.com/), a medical technology company that develops, manufactures, and sells proprietary ...
Prostate cancer is one of the most common cancers for men with more than 183,000 new diagnoses each year. It's a highly treatable cancer, with options ranging from watchful waiting to surgery to ...
“Our phase 3 clinical trial previously demonstrated that SpaceOAR offers a significant benefit in reducing the risk of rectal complications and damage associated with radiation therapy in the ...
Results published in the International Journal of Radiation Oncology Biology and Physics show on average no long-term declines in bowel and urinary quality of life for patients and 78% reduction in ...
First and only prostate cancer spacing device available for use in the U.S. clinically proven to preserve patient quality of life following radiation therapy BEDFORD, Mass.–(BUSINESS WIRE)–November 7, ...
The radiation oncology team at UH Seidman Cancer Center at UH Geauga Medical Center performed the first-ever prostate cancer treatment on April 3 using a newly approved device. The device, called ...
This year, more than 162,000 men will be diagnosed with prostate cancer. Cancer treatment, while life-saving, can cause incontinence and erectile dysfunction, but a new outpatient procedure can ...
GAINESVILLE, Fla., May 31, 2018 /PRNewswire-PRWeb/ -- North Florida Regional Medical Center announces that they are the first and only appliers of SpaceOAR hydrogel in Gainesville, Florida. SpaceOAR ...
WALTHAM, Mass.—April 2, 2015—Augmenix, Inc., a privately held company developing minimally invasive hydrogel products to improve outcomes following cancer radiotherapy, today announced FDA clearance ...
Dr. Varun Sundaram, a urologist at Urology Austin, joined Studio 512 Co-Host Rosie Newberry to talk about SpaceOAR Hydrogel and Rezūm Water Vapor Therapy. “The two treatments we commonly use are ...
The Star Wars Society of San Antonio hosted a food bank charity at the Regal Alamo Quarry on May 23, 2026. NEW YORK CITY, N.Y. (Ivanhoe Newswire) – This year, more than 162,000 men will be diagnosed ...